Cargando…
Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical Trials
IMPORTANCE: Adjuvant drugs are used to reduce the risk of tumor recurrence in patients with cancer who are successfully treated with first-line therapy. The same drugs used in the metastatic or first-line setting are often used in the adjuvant setting, and although the resulting adverse effects may...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112068/ https://www.ncbi.nlm.nih.gov/pubmed/35576006 http://dx.doi.org/10.1001/jamanetworkopen.2022.12327 |